| abstract |
The present invention relates to a biomarker for detecting metastasis of tumor such as colon cancer, esophageal cancer, gastric cancer, breast cancer, lung cancer, medulloblastoma, prostate cancer, lymphoma, melanoma, glioblastoma, pancreas carcinoma, sarcoma, hepatocarcinoma, by means of the detection of copy number and different expression of erbB2 gene in biological fluids of patients with tumors listed above. |